| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.31 | 2e-09 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.27 | 3e-09 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.32 | 1e-08 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.26 | 1e-06 |